Tuesday, 27 February 2024

Korea's Seegene obtains European certification for 30 diagnostic assays

05 June 2023 | News

New regulation sets improved standards to ensure higher level of quality, safety, and reliability

Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, has obtained the European Union's In Vitro Diagnostic Medical Device Regulation (IVDR) certification for 30 diagnostic assays.

The certification covers assays for a range of indications, including eight for gastrointestinal infections (GI), seven for women's diseases, five for respiratory diseases, four for tuberculosis, three for meningitis, two for human papillomavirus (HPV), and one for drug resistance.

The IVDR was established to raise quality standards and ensure that existing European In Vitro Diagnostic Medical Device Directive (IVDD) devices are safe. Seegene has proactively responded to recent regulatory changes and secured the mandatory certification. All manufacturers of in vitro diagnostic devices, such as PCR diagnostic assays, must obtain IVDR certification before selling these medical devices in the European market.

The new regulation aims to increase the effectiveness and safety of medical devices in the EU. The manufacturers must now follow the requirements for post-market surveillance, clinical evidence, and performance evaluation for all medical devices.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account